- GE HealthCare has agreed to acquire Intelligent Ultrasound’s clinical AI software business for $51 million.
- Intelligent Ultrasound is known for its AI-driven image analysis tools that enhance ultrasound technology.
- The acquisition aims to integrate these tools into GE HealthCare’s ultrasound portfolio, improving workflow and user experience.
- Key technologies involved include ScanNav Assist AI and SonoLyst products.
- Intelligent Ultrasound’s R&D team will join GE HealthCare, focusing on AI innovations for Women’s Health ultrasound devices.
- The acquisition follows GE HealthCare’s 2023 purchase of Caption Health and is expected to close in Q4 2024.
- Intelligent Ultrasound will shift focus to its ultrasound simulation technology post-acquisition.
Main AI News:
GE HealthCare has announced an agreement to acquire the clinical artificial intelligence (AI) software business from Intelligent Ultrasound Group PLC for approximately $51 million. Intelligent Ultrasound, known for its AI-driven image analysis tools, will enhance GE HealthCare’s ultrasound portfolio by integrating these solutions to optimize workflows and improve user experience for both clinicians and patients.
Phil Rackliffe, President and CEO of Ultrasound and Image Guided Therapies at GE HealthCare, stated, “Integrating Intelligent Ultrasound’s innovative technology into our Ultrasound portfolio will streamline workflows, reduce repetitive tasks, and simplify examinations. This acquisition will accelerate the development of our next-generation AI tools and enhance our portfolio of AI-enabled devices.”
Intelligent Ultrasound’s ScanNav Assist AI technology, which supports SonoLystlive and SonoLyst X/IR, is already featured on GE HealthCare’s Voluson™ Expert and Voluson Signature ultrasound devices. The acquisition will further bolster GE HealthCare’s AI innovation pipeline and support future advancements.
The acquisition also includes Intelligent Ultrasound’s team of research and development experts, who will contribute to AI-driven image recognition and innovation for GE HealthCare’s Women’s Health ultrasound devices. This move follows GE HealthCare’s 2023 acquisition of Caption Health, which expanded its capabilities in AI image guidance and development.
Nick Sleep, COO of Intelligent Ultrasound, commented, “Joining GE HealthCare will accelerate the adoption of our technology and simplify ultrasound for users.” The integration of these technologies is expected to address the challenges faced by sonographers, including radiology technologist shortages and musculoskeletal disorders from repetitive tasks.
The deal, which is set to close in Q4 2024 pending customary conditions, will be financed with GE HealthCare’s cash reserves. Intelligent Ultrasound will focus on its high-fidelity ultrasound simulation technology for educational purposes following the transaction.
Conclusion:
The acquisition of Intelligent Ultrasound’s clinical AI business by GE HealthCare signifies a strategic move to bolster its capabilities in AI-driven imaging solutions. This integration will enhance GE HealthCare’s ultrasound portfolio, improve clinical workflows, and address common challenges faced by sonographers, such as shortages and repetitive strain injuries. By strengthening its position in the AI-enabled device market, GE HealthCare is likely to gain a competitive edge in medical imaging technology. The transaction aligns with the broader industry trend towards integrating advanced AI solutions to enhance diagnostic efficiency and patient care.
